Sharon Hamm
17Patents
3h-index
9Co-inventors
49Inventor score
Filing activity: Sep 7, 2012 → Nov 14, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10792262B1 | Stabilized formulations of 4-amino-3-substituted butanoic acid derivatives | Human Necessities | 5 | Active |
| US10434248B1 | Kit and method of reducing human error during implanted infusion pump refilling | Human Necessities | 5 | Active |
| US8992973B2 | Controlled release compositions comprising a combination of isosorbide dinitrate and hydralazine hydrochloride | Human Necessities | 4 | Active |
| US11491125B1 | Baclofen formulations and methods of minimizing patient exposure to metabolite variations | Human Necessities | 1 | Active |
| US11654124B2 | Stabilized formulations of 4-amino-3-substituted butanoic acid derivatives | Human Necessities | 1 | Active |
| US12011502B2 | Compositions and methods of administering baclofen | Human Necessities | 0 | Active |
| US10213389B2 | Controlled release compositions comprising a combination of isosorbide dinitrate and hydralazine hydrochloride | Human Necessities | 0 | Active |
| US11931328B2 | Stabilized formulations of 4-amino-3-substituted butanoic acid derivatives | Human Necessities | 0 | Active |
| US11523984B1 | Compositions and methods of administering baclofen | Human Necessities | 0 | Active |
| US11850225B2 | Baclofen formulations and methods of minimizing patient exposure to metabolite variations | Human Necessities | 0 | Active |
| US11083695B2 | Injectable phenol formulations and methods of manufacture | Human Necessities | 0 | Active |
| US10751312B1 | Stabilized formulations of 4-amino-3-substituted butanoic acid derivatives | General | 0 | Revoked |
| US9463166B2 | Controlled release compositions comprising a combination of isosorbide dinitrate and hydralazine hydrochloride | Human Necessities | 0 | Active |
| US11083694B2 | Injectable phenol formulations and methods of their use | Human Necessities | 0 | Active |
| US12383522B2 | Baclofen formulations and methods of minimizing patient exposure to metabolite variations | Human Necessities | 0 | Active |
| US10959962B2 | Injectable phenol formulations and methods of their use | Human Necessities | 0 | Active |
| US9308177B2 | Controlled release compositions comprising a combination of isosorbide dinitrate and hydralazine hydrochloride | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.